Ferran Nadeu/LinkedIn
Oct 22, 2025, 10:46
Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
Touch Medical Media shared on LinkedIn:
”A Conversation with Dr Ferran Nadeu – Touch Haematology Future Leaders 2025
As part of our Future Leaders 2025 series, we spoke with Dr Ferran Nadeu (Hospital Clínic de Barcelona, Spain) about his journey in cancer genomics and haematology.
In this interview, he reflects on the influence of mentorship, the excitement of translational discoveries, and how emerging genomic technologies are transforming our understanding of B-cell malignancies.
Read the full interview.”
More winner stories featured in Hemostasis Today.
-
Oct 13, 2026, 20:50Ruchika Goel: Cord Blood Red Blood Cells as a Physiologically Aligned Transfusion Strategy
-
Oct 13, 2026, 20:47Sophia Delicou: Strengthening Transfusion Safety Through Advanced Screening and Haemovigilance
-
Oct 13, 2026, 20:45Lydia Pecker: Alloimmunization and Transfusion Indications in Sickle Cell Disease Pregnancy
-
Oct 13, 2026, 15:51Merel Timmer: Hemophilia Twinning Partnership Strengthens Care and Quality of Life in Indonesia
-
Oct 13, 2026, 15:41Sarah Alam: ASH 2026 Guidelines on Iron Deficiency Diagnosis and Updated Ferritin Thresholds
-
Oct 13, 2026, 15:35Jamie Elmawieh: Prophylactic Anticoagulation Improves Survival in Isolated Tumor Thrombus
-
Oct 13, 2026, 15:30Sally Mandour: Methemoglobinemia When Hemoglobin Cannot Carry Oxygen
-
Oct 13, 2026, 15:21Renel Tique: Advancing Hemophilia Care Through Global Collaboration and Clinical Innovation
-
Oct 13, 2026, 15:08Anastasia Chatzistamati: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome